Barclays PLC Boosts Stake in Anterix Inc. (NASDAQ:ATEX)

Barclays PLC boosted its position in shares of Anterix Inc. (NASDAQ:ATEX - Free Report) by 124.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,025 shares of the company's stock after acquiring an additional 21,054 shares during the quarter. Barclays PLC owned 0.20% of Anterix worth $1,166,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. DG Capital Management LLC bought a new position in shares of Anterix during the fourth quarter worth $13,158,000. ExodusPoint Capital Management LP purchased a new position in Anterix in the 4th quarter worth about $2,405,000. Vanguard Group Inc. boosted its holdings in shares of Anterix by 3.5% in the fourth quarter. Vanguard Group Inc. now owns 1,034,979 shares of the company's stock valued at $31,743,000 after purchasing an additional 34,836 shares during the period. JPMorgan Chase & Co. lifted its stake in Anterix by 91.2% in the fourth quarter. JPMorgan Chase & Co. now owns 64,692 shares of the company's stock worth $1,984,000 after acquiring an additional 30,860 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its position in Anterix by 8,107.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,080 shares of the company's stock valued at $333,000 after acquiring an additional 10,945 shares in the last quarter. 87.67% of the stock is owned by hedge funds and other institutional investors.

Anterix Trading Down 0.4 %

Shares of NASDAQ ATEX opened at $29.84 on Monday. The company has a 50 day simple moving average of $34.88 and a two-hundred day simple moving average of $33.40. The stock has a market cap of $554.64 million, a price-to-earnings ratio of -18.31 and a beta of 0.94. Anterix Inc. has a 12 month low of $27.37 and a 12 month high of $42.91.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. increased their price objective on Anterix from $61.00 to $67.00 and gave the company an "overweight" rating in a report on Thursday, February 13th.

Anterix Profile

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.